SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Applied Materials Inc/DE – ‘10-Q’ for 7/31/16 – ‘R12’

On:  Thursday, 8/25/16, at 4:18pm ET   ·   For:  7/31/16   ·   Accession #:  6951-16-59   ·   File #:  0-06920

Previous ‘10-Q’:  ‘10-Q’ on 5/26/16 for 5/1/16   ·   Next:  ‘10-Q’ on 2/23/17 for 1/29/17   ·   Latest:  ‘10-Q’ on 2/27/24 for 1/28/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/25/16  Applied Materials Inc/DE          10-Q        7/31/16   86:10M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.06M 
 2: EX-31.1     Certification of Chief Executive Officer Pursuant   HTML     30K 
                to Section 302                                                   
 3: EX-31.2     Certification of Chief Financial Officer Pursuant   HTML     30K 
                to Section 302                                                   
 4: EX-32.1     Certification of Chief Executive Officer Pursuant   HTML     26K 
                to Section 906                                                   
 5: EX-32.2     Certification of Chief Financial Officer Pursuant   HTML     26K 
                to Section 906                                                   
12: R1          Document and Entity Information                     HTML     43K 
13: R2          Consolidated Condensed Statements of Operations     HTML     79K 
14: R3          Consolidated Condensed Statements of Comprehensive  HTML     51K 
                Income                                                           
15: R4          Consolidated Condensed Balance Sheets               HTML     99K 
16: R5          Consolidated Condensed Statements of Stockholders'  HTML     71K 
                Equity                                                           
17: R6          Consolidated Condensed Statements of Stockholders'  HTML     28K 
                Equity (Parenthetical)                                           
18: R7          Consolidated Condensed Statements of Cash Flows     HTML    110K 
19: R8          Basis of Presentation                               HTML     44K 
20: R9          Earnings Per Share                                  HTML     60K 
21: R10         Cash, Cash Equivalents and Investments              HTML    158K 
22: R11         Fair Value Measurements                             HTML     87K 
23: R12         Derivative Instruments and Hedging Activities       HTML    142K 
24: R13         Accounts Receivable, Net                            HTML     31K 
25: R14         Balance Sheet Detail                                HTML    108K 
26: R15         Goodwill, Purchased Technology and Other            HTML    191K 
                Intangible Assets                                                
27: R16         Borrowing Facilities and Debt                       HTML     73K 
28: R17         Stockholders' Equity, Comprehensive Income and      HTML    148K 
                Share-Based Compensation                                         
29: R18         Employee Benefit Plans                              HTML     51K 
30: R19         Income Taxes                                        HTML     31K 
31: R20         Warranty, Guarantees and Contingencies              HTML     55K 
32: R21         Industry Segment Operations                         HTML    105K 
33: R22         Basis of Presentation (Policies)                    HTML    102K 
34: R23         Earnings Per Share (Tables)                         HTML     57K 
35: R24         Cash, Cash Equivalents and Investments (Tables)     HTML    154K 
36: R25         Fair Value Measurements (Tables)                    HTML     71K 
37: R26         Derivative Instruments and Hedging Activities       HTML    127K 
                (Tables)                                                         
38: R27         Balance Sheet Detail (Tables)                       HTML    117K 
39: R28         Goodwill, Purchased Technology and Other            HTML    186K 
                Intangible Assets (Tables)                                       
40: R29         Borrowing Facilities and Debt (Tables)              HTML     71K 
41: R30         Stockholders' Equity, Comprehensive Income and      HTML    146K 
                Share-Based Compensation (Tables)                                
42: R31         Employee Benefit Plans (Tables)                     HTML     50K 
43: R32         Warranty, Guarantees And Contingencies (Tables)     HTML     48K 
44: R33         Industry Segment Operations (Tables)                HTML    101K 
45: R34         Basis of Presentation (Details)                     HTML     26K 
46: R35         Earnings Per Share (Details)                        HTML     51K 
47: R36         Cash, Cash Equivalents and Investments (Summary of  HTML     95K 
                Cash, Cash Equivalents and Investments) (Details)                
48: R37         Cash, Cash Equivalents and Investments (Details)    HTML     47K 
49: R38         Fair Value Measurements (Details)                   HTML     67K 
50: R39         Fair Value Measurements (Details Textual)           HTML     48K 
51: R40         Derivative Instruments and Hedging Activities       HTML     49K 
                (Details Textual)                                                
52: R41         Derivative Instruments and Hedging Activities       HTML     47K 
                (Derivatives in Statements of Operations)                        
                (Details)                                                        
53: R42         Derivative Instruments and Hedging Activities       HTML     36K 
                (Gain/Loss Recognized in Income) (Details)                       
54: R43         Accounts Receivable, Net (Details)                  HTML     29K 
55: R44         Balance Sheet Detail (Inventories) (Details)        HTML     41K 
56: R45         Balance Sheet Detail (Other Current Assets)         HTML     37K 
                (Details)                                                        
57: R46         Balance Sheet Detail (Property, Plant and           HTML     56K 
                Equipment) (Details)                                             
58: R47         Balance Sheet Detail (Accounts Payable and Accrued  HTML     52K 
                Expense) (Details)                                               
59: R48         Balance Sheet Detail (Customer Deposits and         HTML     34K 
                Deferred Revenue) (Details)                                      
60: R49         Balance Sheet Detail (Other Liabilities) (Details)  HTML     39K 
61: R50         Goodwill, Purchased Technology and Other            HTML     40K 
                Intangible Assets (Schedule of Goodwill and Other                
                Indefinite-lived Intangible Assets) (Details)                    
62: R51         Goodwill, Purchased Technology and Other            HTML     37K 
                Intangible Assets (Schedule of Purchased                         
                Technology and Intangible Assets) (Details)                      
63: R52         Goodwill, Purchased Technology and Other            HTML     36K 
                Intangible Assets (Details Textual)                              
64: R53         Goodwill, Purchased Technology and Other            HTML     60K 
                Intangible Assets (Schedule of Finite-lived                      
                Intangible Assets) (Details)                                     
65: R54         Goodwill, Purchased Technology and Other            HTML     39K 
                Intangible Assets (Amortization Expense by                       
                Segment) (Details)                                               
66: R55         Goodwill, Purchased Technology and Other            HTML     38K 
                Intangible Assets (Amortization Expense) (Details)               
67: R56         Goodwill, Purchased Technology and Other            HTML     41K 
                Intangible Assets (Estimated Amortization Expense)               
                (Details)                                                        
68: R57         Borrowing Facilities and Debt (Details Textual)     HTML     58K 
69: R58         Borrowing Facilities and Debt (Details)             HTML     74K 
70: R59         Stockholders' Equity, Comprehensive Income and      HTML     55K 
                Share-Based Compensation (Changes in Components of               
                AOCI) (Details)                                                  
71: R60         Stockholders' Equity, Comprehensive Income and      HTML     98K 
                Share-Based Compensation (Details Textual)                       
72: R61         Stockholders' Equity, Comprehensive Income and      HTML     33K 
                Share-Based Compensation (Stock Repurchase                       
                Program) (Details)                                               
73: R62         Stockholders' Equity, Comprehensive Income and      HTML     39K 
                Share-Based Compensation (Share-Based                            
                Compensation) (Details)                                          
74: R63         Stockholders' Equity, Comprehensive Income and      HTML     51K 
                Share-Based Compensation (Restricted Stock Units,                
                Restricted Stock, Performance Shares and                         
                Performance Units) (Details)                                     
75: R64         Stockholders' Equity, Comprehensive Income and      HTML     39K 
                Share-Based Compensation (Valuation Assumptions)                 
                (Details) (Details)                                              
76: R65         Employee Benefit Plans (Details)                    HTML     42K 
77: R66         Income Taxes (Details Textual)                      HTML     33K 
78: R67         Warranty, Guarantees and Contingencies (Details)    HTML     35K 
79: R68         Warranty, Guarantees and Contingencies (Details     HTML     36K 
                Textual)                                                         
80: R69         Industry Segment Operations (Details Textual)       HTML     26K 
81: R70         Industry Segment Operations (Net Sales and          HTML     42K 
                Operating Income (Loss)) (Details)                               
82: R71         Industry Segment Operations (Reconciliations of     HTML     45K 
                Total Segment) (Details)                                         
83: R72         Industry Segment Operations (Percentage of New      HTML     38K 
                Sales) (Details)                                                 
85: XML         IDEA XML File -- Filing Summary                      XML    165K 
84: EXCEL       IDEA Workbook of Financial Reports                  XLSX     95K 
 6: EX-101.INS  XBRL Instance -- amat-20160731                       XML   3.30M 
 8: EX-101.CAL  XBRL Calculations -- amat-20160731_cal               XML    247K 
 9: EX-101.DEF  XBRL Definitions -- amat-20160731_def                XML    586K 
10: EX-101.LAB  XBRL Labels -- amat-20160731_lab                     XML   1.56M 
11: EX-101.PRE  XBRL Presentations -- amat-20160731_pre              XML    930K 
 7: EX-101.SCH  XBRL Schema -- amat-20160731                         XSD    164K 
86: ZIP         XBRL Zipped Folder -- 0000006951-16-000059-xbrl      Zip    251K 


‘R12’   —   Derivative Instruments and Hedging Activities


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.5.0.2
Derivative Instruments and Hedging Activities
9 Months Ended
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments and Hedging Activities
Derivative Instruments and Hedging Activities
Derivative Financial Instruments
Applied conducts business in a number of foreign countries, with certain transactions denominated in local currencies, such as the Japanese yen, euro, Israeli shekel and Taiwanese dollar. Applied uses derivative financial instruments, such as forward exchange contracts and currency option contracts, to hedge certain forecasted foreign currency denominated transactions expected to occur typically within the next 24 months. The purpose of Applied’s foreign currency management is to mitigate the effect of exchange rate fluctuations on certain foreign currency denominated revenues, costs and eventual cash flows. The terms of currency instruments used for hedging purposes are generally consistent with the timing of the transactions being hedged.
During fiscal 2015, Applied entered into and settled a series of forward-starting interest rate swap agreements, with a total notional amount of $600 million to hedge against the variability of cash flows due to changes in the benchmark interest rate of fixed rate debt. These instruments were designated as cash flow hedges at inception and settled in conjunction with the issuance of debt in September 2015. The loss from the settlement of the interest rate swap agreement that was included in accumulated other comprehensive income (AOCI) in stockholders' equity is being amortized to interest expense over the term of the senior unsecured 10-year notes issued in September 2015.
Applied does not use derivative financial instruments for trading or speculative purposes. Derivative instruments and hedging activities, including foreign currency exchange contracts and interest rate swap agreements, are recognized on the balance sheet at fair value. Changes in the fair value of derivatives that do not qualify for hedge treatment, as well as the ineffective portion of any hedges, are recognized currently in earnings. All of Applied’s derivative financial instruments are recorded at their fair value in other current assets or in accounts payable and accrued expenses.
 
Hedges related to anticipated transactions are designated and documented at the inception of the hedge as cash flow hedges and foreign exchange derivatives are typically entered into once per month. Cash flow hedges are evaluated for effectiveness quarterly. The effective portion of the gain or loss on these hedges is reported as a component of AOCI in stockholders’ equity and is reclassified into earnings when the hedged transaction affects earnings. The majority of the after-tax net income or loss related to foreign exchange derivative instruments included in AOCI at July 31, 2016 is expected to be reclassified into earnings within 12 months. Changes in the fair value of currency forward exchange and option contracts due to changes in time value are excluded from the assessment of effectiveness. Both ineffective hedge amounts and hedge components excluded from the assessment of effectiveness are recognized in earnings. If the transaction being hedged is no longer probable to occur, or if a portion of any derivative is deemed to be ineffective, Applied promptly recognizes the gain or loss on the associated financial instrument in earnings. The amount recognized due to discontinuance of cash flow hedges that were probable not to occur by the end of the originally specified time period was not significant for the three and nine months ended July 31, 2016 and July 26, 2015.
Additionally, forward exchange contracts are generally used to hedge certain foreign currency denominated assets or liabilities. These derivatives are typically entered into once per month and are not designated for hedge accounting treatment. Accordingly, changes in the fair value of these hedges are recorded in earnings to offset the changes in the fair value of the assets or liabilities being hedged.
In September 2013, Applied purchased foreign exchange option contracts to limit its foreign exchange risk associated with the then-anticipated business combination with Tokyo Electron Limited (TEL). These derivatives did not qualify for hedge accounting treatment and were marked to market at the end of each reporting period with gains and losses recorded as part of operating expenses. Due to the termination of the then-anticipated business combination with TEL on April 26, 2015, these foreign exchange option contracts were sold during the third quarter of fiscal 2015. During the three and nine months ended July 26, 2015, Applied recorded a loss of $3 million and a gain of $89 million, respectively, related to these contracts. The cash flow impact of these derivatives has been classified as operating cash flows in the Consolidated Condensed Statements of Cash Flows.
The fair values of foreign exchange derivative instruments at July 31, 2016 and October 25, 2015 were not material.


The effects of derivative instruments and hedging activities on the Consolidated Condensed Statements of Operations were as follows:
 
 
 
Three Months Ended
 
 
 
 
Effective Portion
 
Ineffective Portion and Amount
Excluded from
Effectiveness
Testing
 
Effective Portion
 
Ineffective Portion and Amount
Excluded from
Effectiveness
Testing
 
Location of Gain or
(Loss) Reclassified
from AOCI into
Income
 
Gain or
(Loss)
Recognized
in AOCI
 
Gain or (Loss)
Reclassified
from AOCI into
Income
 
Gain or (Loss)
Recognized in
Income
 
Gain or
(Loss)
Recognized
in AOCI
 
Gain or (Loss)
Reclassified
from AOCI into
Income
 
Gain or (Loss)
Recognized in
Income
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In millions)
Derivatives in Cash Flow Hedging Relationships
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
Cost of products sold
 
$
(26
)
 
$
(13
)
 
$
1

 
$
5

 
$
2

 
$
(1
)
Foreign exchange contracts
General and administrative
 

 
1

 
(1
)
 

 
3

 

Interest rate swaps
Interest expense
 

 
(1
)
 

 
$
(8
)
 
$

 
$

Total
 
 
$
(26
)
 
$
(13
)
 
$

 
$
(3
)
 
$
5

 
$
(1
)

 
 
 
Nine Months Ended
 
Effective Portion
 
Ineffective Portion and Amount
Excluded from
Effectiveness
Testing
 
Effective Portion
 
Ineffective Portion and Amount
Excluded from
Effectiveness
Testing
 
Location of Gain or
(Loss) Reclassified
from AOCI into
Income
 
Gain or
(Loss)
Recognized
in AOCI
 
Gain or (Loss)
Reclassified
from AOCI into
Income
 
Gain or (Loss)
Recognized in
Income
 
Gain or
(Loss)
Recognized
in AOCI
 
Gain or (Loss)
Reclassified
from AOCI into
Income
 
Gain or (Loss)
Recognized in
Income
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In millions)
Derivatives in Cash Flow Hedging Relationships
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
Cost of products sold
 
$
(49
)
 
$
(21
)
 
$
1

 
$
10

 
$
15

 
$
(3
)
Foreign exchange contracts
General and administrative
 

 
(1
)
 
(2
)
 

 
(5
)
 
(1
)
Interest rate swaps
Interest expense
 

 
(1
)
 

 
(8
)
 

 

Total
 
 
$
(49
)
 
$
(23
)
 
$
(1
)
 
$
2

 
$
10

 
$
(4
)



 
 
 
Amount of Gain or (Loss) 
Recognized in Income
 
 
Three Months Ended
 
Nine Months Ended
Location of Gain or
(Loss) Recognized
in Income
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In millions)
Derivatives Not Designated as Hedging Instruments
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
Gain on derivatives associated with terminated business combination
 
$

 
$
(3
)
 
$

 
$
89

Foreign exchange contracts
General and
administrative
 
(31
)
 
11

 
(67
)
 
31

Total
 
 
$
(31
)
 
$
8

 
$
(67
)
 
$
120


 
Credit Risk Contingent Features
If Applied’s credit rating were to fall below investment grade, it would be in violation of credit risk contingent provisions of the derivative instruments discussed above, and certain counterparties to the derivative instruments could request immediate payment on derivative instruments in net liability positions. The aggregate fair value of all derivative instruments with credit-risk related contingent features that were in a net liability position was immaterial as of July 31, 2016.
Entering into derivative contracts with banks exposes Applied to credit-related losses in the event of the banks’ nonperformance. However, Applied’s exposure is not considered significant.

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/25/164
For Period end:7/31/16
10/25/1510-K
7/26/1510-Q
4/26/1510-Q,  8-K
 List all Filings 
Top
Filing Submission 0000006951-16-000059   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 12:25:29.1pm ET